Foley Todd
10% owner at TRDA; 10% owner at ITOS; Director at Repare Therapeutics Inc., and 2 more
- Sold, on record
- $77.4M
- Dollars the filings state
- Form 4 sales
- 39
- Latest Aug 26, 2026
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 1 of the last 8
- 1 day with a sale in that time
- Companies
- 5
- Filed as an executive or holder
Companies
- TRDAEntrada Therapeutics, Inc.10% owner
- ITOSiTeos Therapeutics, Inc.10% owner
- Repare Therapeutics Inc.Director
- RYTMRHYTHM PHARMACEUTICALS, INC.Director
- ARATANA THERAPEUTICS, INC.10% owner
Sales by reason
0
Routine
35
Plan not stated
1
No plan
3
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- RYTM2.2M shares
- Repare Therapeutics Inc.715,031 shares
- ITOS143,247 shares
- TRDA62,714 shares
- ARATANA THERAPEUTICS, INC.12,539 shares
Shares sold, every Form 4 sale on record.
Timeline
- Aug 26, 2026No plan
Sold 1.4% of their holdings
$462k62,714 shares at $7.36
- Oct 11, 2021Plan not stated
Sold 1.6% of their holdings
$1.4M51,993 shares at $27.23
- Sep 20, 2021Plan not stated
Sold 2.6% of their holdings
$2.6M91,254 shares at $28.38
- Jul 12, 2021Plan not stated
Sold 1.2% of their holdings
$918k27,351 shares at $33.55
- Jun 29, 2021Plan not stated
Sold 0.4% of their holdings
$288k8,460 shares at $34.06
- Jun 25, 2021Plan not stated
Sold 0.6% of their holdings
$424k12,640 shares at $33.51
- Jun 23, 2021Plan not stated
Sold 0.8% of their holdings
$648k18,859 shares at $34.36
- Jun 18, 2021Plan not stated
Sold 0.8% of their holdings
$618k18,294 shares at $33.77
- Jun 16, 2021Plan not stated
Sold 0.1% of their holdings
$91k2,743 shares at $33.25
- Jun 9, 2021Plan not stated
Sold 1.1% of their holdings
$922k27,067 shares at $34.05
10 of 39
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Aug 26, 2026 | TRDA | 10% owner | Sold | 62,714 | $7.36 | $462k | 4.3M | SEC |
| Jan 12, 2026 | Jan 14, 2026 | AKTS | Director, 10% owner | Bought | 232,870 | $18.00 | $4.2M | 4.2M | SEC |
| Jan 12, 2026 | Jan 14, 2026 | AKTS | Director, 10% owner | ConvertedSeries Seed Redeemable Convertible Preferred Stock | 15.2M | 0 | SEC | ||
| Jan 12, 2026 | Jan 14, 2026 | AKTS | Director, 10% owner | Converted | 4M | 4M | SEC | ||
| Jun 8, 2023 | Jun 12, 2023 | Repare Therapeutics Inc. | Director | AwardedStock Option (right to buy) | 27,200 | 27,200 | SEC | ||
| Jun 2, 2022 | Jun 6, 2022 | TRDA | Director, 10% owner | AwardedStock Option (Right to Buy) | 11,918 | 11,918 | SEC | ||
| May 13, 2022 | May 16, 2022 | Repare Therapeutics Inc. | Director | AwardedStock Option (right to buy) | 49,000 | 49,000 | SEC | ||
| Nov 2, 2021 | Nov 4, 2021 | TRDA | Director, 10% owner | Bought | 100,000 | $20.00 | $2M | 4.4M | SEC |
| Nov 2, 2021 | Nov 4, 2021 | TRDA | Director, 10% owner | ConvertedSeries A Preferred Stock | 31.3M | 0 | SEC | ||
| Nov 2, 2021 | Nov 4, 2021 | TRDA | Director, 10% owner | Converted | 4.3M | 4.3M | SEC | ||
| Oct 28, 2021 | Nov 1, 2021 | TRDA | Director, 10% owner | AwardedStock Option (Right to Buy) | 23,552 | 23,552 | SEC | ||
| Oct 11, 2021 | Oct 12, 2021 | ITOS | 10% owner | Sold | 51,993 | $27.23 | $1.4M | 3.2M | SEC |
| Sep 20, 2021 | Sep 20, 2021 | ITOS | 10% owner | Sold | 91,254 | $28.38 | $2.6M | 3.4M | SEC |
| Aug 5, 2021 | Aug 5, 2021 | CHIASMA, INC | Director | Returned to the companyStock Option (Right to Buy) | 62,000 | 0 | SEC | ||
| Jul 12, 2021 | Jul 13, 2021 | Repare Therapeutics Inc. | Director | Sold | 27,351 | $33.55 | $918k | 2.2M | SEC |
| Jun 29, 2021 | Jun 30, 2021 | Repare Therapeutics Inc. | Director | Sold | 8,460 | $34.06 | $288k | 2.3M | SEC |
| Jun 25, 2021 | Jun 28, 2021 | Repare Therapeutics Inc. | Director | Sold | 12,640 | $33.51 | $424k | 2.3M | SEC |
| Jun 23, 2021 | Jun 23, 2021 | Repare Therapeutics Inc. | Director | Sold | 18,859 | $34.36 | $648k | 2.3M | SEC |
| Jun 18, 2021 | Jun 21, 2021 | Repare Therapeutics Inc. | Director | Sold | 18,294 | $33.77 | $618k | 2.3M | SEC |
| Jun 16, 2021 | Jun 16, 2021 | Repare Therapeutics Inc. | Director | Sold | 2,743 | $33.25 | $91k | 2.3M | SEC |
| Jun 9, 2021 | Jun 10, 2021 | Repare Therapeutics Inc. | Director | Sold | 27,067 | $34.05 | $922k | 2.3M | SEC |
| Jun 7, 2021 | Jun 7, 2021 | Repare Therapeutics Inc. | Director | Sold | 25,622 | $32.01 | $820k | 2.4M | SEC |
| Jun 2, 2021 | Jun 2, 2021 | Repare Therapeutics Inc. | Director | Sold | 16,786 | $32.47 | $545k | 2.4M | SEC |
| May 27, 2021 | May 27, 2021 | Repare Therapeutics Inc. | Director | Sold | 16,989 | $32.82 | $558k | 2.4M | SEC |
| May 24, 2021 | May 24, 2021 | Repare Therapeutics Inc. | Director | Sold | 143,141 | $34.75 | $5M | 2.4M | SEC |
| May 20, 2021 | May 20, 2021 | Repare Therapeutics Inc. | Director | Sold | 20,667 | $34.37 | $710k | 2.6M | SEC |
| May 18, 2021 | May 20, 2021 | Repare Therapeutics Inc. | Director | Other | 21,834 | 2.6M | SEC | ||
| May 13, 2021 | May 14, 2021 | Repare Therapeutics Inc. | Director | AwardedStock Option (right to buy) | 21,000 | 21,000 | SEC | ||
| Mar 15, 2021 | Mar 16, 2021 | RYTM | Director | Sold | 1M | $25.10 | $25.1M | 909,258 | SEC |
| Mar 15, 2021 | Mar 15, 2021 | Repare Therapeutics Inc. | Director | Other | 24,271 | 2.6M | SEC | ||
| Mar 12, 2021 | Mar 15, 2021 | Repare Therapeutics Inc. | Director | Sold | 376,412 | $28.18 | $10.6M | 2.6M | SEC |
| Jun 26, 2020 | Jun 30, 2020 | RYTM | Director | Sold | 300 | $25.04 | $8k | 1.9M | SEC |
| Jun 25, 2020 | Jun 25, 2020 | RYTM | Director | Sold | 115,335 | $25.35 | $2.9M | 1.9M | SEC |
| Jun 23, 2020 | Jun 25, 2020 | Repare Therapeutics Inc. | Director | Bought | 250,000 | $20.00 | $5M | 3M | SEC |
| Jun 23, 2020 | Jun 25, 2020 | Repare Therapeutics Inc. | Director | ConvertedClass A Preferred Shares | 2.8M | 0 | SEC | ||
| Jun 23, 2020 | Jun 25, 2020 | Repare Therapeutics Inc. | Director | Converted | 2.8M | 2.8M | SEC | ||
| Jun 17, 2020 | Jun 18, 2020 | RYTM | Director | AwardedStock Option (right to buy) | 18,500 | 18,500 | SEC | ||
| Jun 11, 2020 | Jun 12, 2020 | CHIASMA, INC | Director | AwardedStock Option (Right to Buy) | 13,000 | 13,000 | SEC | ||
| Jun 5, 2020 | Jun 5, 2020 | RYTM | Director | Sold | 1,896 | $20.00 | $38k | 2M | SEC |
| Jun 3, 2020 | Jun 3, 2020 | RYTM | Director | Sold | 44,358 | $20.21 | $897k | 2M | SEC |
| May 28, 2020 | May 28, 2020 | RYTM | Director | Sold | 29,300 | $20.17 | $591k | 2.1M | SEC |
| May 26, 2020 | May 26, 2020 | RYTM | Director | Sold | 96,921 | $20.32 | $2M | 2.1M | SEC |
| May 20, 2020 | May 20, 2020 | RYTM | Director | Sold | 34,509 | $20.00 | $690k | 2.2M | SEC |
| May 13, 2020 | May 15, 2020 | RYTM | Director | Sold | 1,837 | $20.04 | $37k | 2.2M | SEC |
| May 12, 2020 | May 12, 2020 | RYTM | Director | Sold | 53,130 | $20.25 | $1.1M | 2.2M | SEC |
| May 7, 2020 | May 7, 2020 | RYTM | Director | Sold | 1,826 | $20.00 | $37k | 2.3M | SEC |
| Apr 29, 2020 | Apr 30, 2020 | RYTM | Director | Sold | 36,223 | $20.10 | $728k | 2.3M | SEC |
| Apr 1, 2020 | Apr 1, 2020 | RYTM | Director | Sold | 34,570 | $15.13 | $523k | 2.3M | SEC |
| Mar 26, 2020 | Mar 30, 2020 | RYTM | Director | Sold | 2,300 | $15.04 | $35k | 2.4M | SEC |
| Mar 20, 2020 | Mar 24, 2020 | RYTM | Director | Sold | 1,100 | $15.00 | $17k | 2.4M | SEC |
Page 1
Sales and notices (39)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Aug 26, 2026 | TRDA | 10% owner | Form 4 sale | 62,714 | $462k | 1.4% | No plan | SEC |
| Oct 11, 2021 | Oct 12, 2021 | ITOS | 10% owner | Form 4 sale | 51,993 | $1.4M | 1.6% | Plan not stated | SEC |
| Sep 20, 2021 | Sep 20, 2021 | ITOS | 10% owner | Form 4 sale | 91,254 | $2.6M | 2.6% | Plan not stated | SEC |
| Jul 12, 2021 | Jul 13, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 27,351 | $918k | 1.2% | Plan not stated | SEC |
| Jun 29, 2021 | Jun 30, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 8,460 | $288k | 0.4% | Plan not stated | SEC |
| Jun 25, 2021 | Jun 28, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 12,640 | $424k | 0.6% | Plan not stated | SEC |
| Jun 23, 2021 | Jun 23, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 18,859 | $648k | 0.8% | Plan not stated | SEC |
| Jun 18, 2021 | Jun 21, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 18,294 | $618k | 0.8% | Plan not stated | SEC |
| Jun 16, 2021 | Jun 16, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 2,743 | $91k | 0.1% | Plan not stated | SEC |
| Jun 9, 2021 | Jun 10, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 27,067 | $922k | 1.1% | Plan not stated | SEC |
| Jun 7, 2021 | Jun 7, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 25,622 | $820k | 1.1% | Plan not stated | SEC |
| Jun 2, 2021 | Jun 2, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 16,786 | $545k | 0.7% | Plan not stated | SEC |
| May 27, 2021 | May 27, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 16,989 | $558k | 0.7% | Plan not stated | SEC |
| May 24, 2021 | May 24, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 143,141 | $5M | 5.6% | Plan not stated | SEC |
| May 20, 2021 | May 20, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 20,667 | $710k | 0.8% | Plan not stated | SEC |
| Mar 15, 2021 | Mar 16, 2021 | RYTM | Director | Form 4 sale | 1M | $25.1M | 52.4% | Unusual | SEC |
| Mar 12, 2021 | Mar 15, 2021 | Repare Therapeutics Inc. | Director | Form 4 sale | 376,412 | $10.6M | 12.5% | Plan not stated | SEC |
| Jun 26, 2020 | Jun 30, 2020 | RYTM | Director | Form 4 sale | 300 | $8k | 0.0% | Plan not stated | SEC |
| Jun 25, 2020 | Jun 25, 2020 | RYTM | Director | Form 4 sale | 115,335 | $2.9M | 5.7% | Unusual | SEC |
| Jun 5, 2020 | Jun 5, 2020 | RYTM | Director | Form 4 sale | 1,896 | $38k | 0.1% | Plan not stated | SEC |
| Jun 3, 2020 | Jun 3, 2020 | RYTM | Director | Form 4 sale | 44,358 | $897k | 2.1% | Plan not stated | SEC |
| May 28, 2020 | May 28, 2020 | RYTM | Director | Form 4 sale | 29,300 | $591k | 1.4% | Plan not stated | SEC |
| May 26, 2020 | May 26, 2020 | RYTM | Director | Form 4 sale | 96,921 | $2M | 4.4% | Plan not stated | SEC |
| May 20, 2020 | May 20, 2020 | RYTM | Director | Form 4 sale | 34,509 | $690k | 1.5% | Plan not stated | SEC |
| May 13, 2020 | May 15, 2020 | RYTM | Director | Form 4 sale | 1,837 | $37k | 0.1% | Plan not stated | SEC |
| May 12, 2020 | May 12, 2020 | RYTM | Director | Form 4 sale | 53,130 | $1.1M | 2.3% | Plan not stated | SEC |
| May 7, 2020 | May 7, 2020 | RYTM | Director | Form 4 sale | 1,826 | $37k | 0.1% | Plan not stated | SEC |
| Apr 29, 2020 | Apr 30, 2020 | RYTM | Director | Form 4 sale | 36,223 | $728k | 1.6% | Plan not stated | SEC |
| Apr 1, 2020 | Apr 1, 2020 | RYTM | Director | Form 4 sale | 34,570 | $523k | 1.5% | Plan not stated | SEC |
| Mar 26, 2020 | Mar 30, 2020 | RYTM | Director | Form 4 sale | 2,300 | $35k | 0.1% | Plan not stated | SEC |
| Mar 20, 2020 | Mar 24, 2020 | RYTM | Director | Form 4 sale | 1,100 | $17k | 0.0% | Plan not stated | SEC |
| Mar 19, 2020 | Mar 19, 2020 | RYTM | Director | Form 4 sale | 30,634 | $463k | 1.3% | Plan not stated | SEC |
| Dec 12, 2019 | Dec 13, 2019 | RYTM | Director | Form 4 sale | 17,362 | $436k | 0.7% | Plan not stated | SEC |
| Dec 10, 2019 | Dec 11, 2019 | RYTM | Director | Form 4 sale | 64,034 | $1.6M | 2.6% | Plan not stated | SEC |
| Dec 3, 2019 | Dec 3, 2019 | RYTM | Director | Form 4 sale | 42,143 | $933k | 1.7% | Plan not stated | SEC |
| Nov 29, 2019 | Nov 29, 2019 | RYTM | Director | Form 4 sale | 127,544 | $2.9M | 4.8% | Plan not stated | SEC |
| Nov 25, 2019 | Nov 26, 2019 | RYTM | Director | Form 4 sale | 224,025 | $5M | 7.8% | Plan not stated | SEC |
| Nov 21, 2019 | Nov 22, 2019 | RYTM | Director | Form 4 sale | 206,288 | $4.4M | 6.7% | Plan not stated | SEC |
| Mar 7, 2014 | Mar 11, 2014 | ARATANA THERAPEUTICS, INC. | 10% owner | Form 4 sale | 12,539 | $250k | 100.0% | Unusual | SEC |